This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Swartz, L. Articles by Stein, D. J. Search for Related Content PubMed PubMed Citation Articles by Swartz, L. Articles by Stein, D. J. Pubmed/NCBI databases Medline Plus Health Information Child Behavior Disorders Clinical Trials Social Bookmarking                   What's this?

Social and Behavioral Aspects of Child and Adolescent Participation in HIV Vaccine Trials

Sociobehavioural Group, South African AIDS Vaccine Initiative (SAAVI), South Africa; Department of Psychology, University of Stellenbosch, Private Bag X1, Matieland, 7602, South Africa; lswartz{at}sun.ac.za

Ashraf Kagee, PhD, MPH

Zuhayr Kafaar, MA (Psychology)

Sociobehavioural Group, South African AIDS Vaccine Initiative (SAAVI), South Africa; Department of Psychology, University of Stellenbosch, South Africa

Joalida Smit, MA (Clin Psych)

Department of Psychiatry, University of Stellenbosch/Anxiety and Stress Disorders Unit, Medical Research Council, South Africa

Arvin Bhana, PhD

Child Youth and Family Development, Human Sciences Research Council, South Africa

Glenda Gray, MBBCH FCPaeds (SA)

Perinatal HIV Research Unit, University of the Witwatersrand, South Africa

Anthea Lesch, MComm, MSc

Sociobehavioural Group, South African AIDS Vaccine Initiative (SAAVI), South Africa; Department of Psychology, University of Stellenbosch, South Africa

Graham Lindegger, PhD

Cecilia Milford, MSocSc

HIV AIDS Vaccine Ethics Group, SAAVI/School of Psychology, University of KwaZulu Natal, South Africa

Linda Richter, PhD

Child Youth and Family Development, Human Sciences Research Council, South Africa

Soraya Seedat, MB, ChB, MMed (Psych), FCPsych, PhD

Department of Psychiatry, University of Stellenbosch/Anxiety and Stress Disorders Unit, Medical Research Council, South Africa

Nokuthula Skhosana, MA (Anthropology)

Perinatal HIV Research Unit, University of the Witwatersrand, South Africa

Dan J. Stein, FRCPC, PhD

Department of Psychiatry, University of Cape Town/Anxiety and Stress Disorders Unit, Medical Research Council, South Africa

Recent data indicate that the worldwide rate of HIV infection in adolescents is steadily increasing. Internationally, more than 7000 youths between 15 and 24 years of age are infected with HIV daily, resulting in more than 2.5 million new infections annually. Almost two thirds (1.7 million) of these new infections occur in Africa. Estimates in 2000 showed that the number of South Africans between 15 and 49 years of age infected with HIV was 4.7 million. This number equates to a prevalence rate of 15.4% in those younger than 20 years. Adolescents form an important target group not only for preventative efforts but also for HIV vaccine trials. This article focuses on the social and psychological factors that affect adolescent decision making by considering adolescent risk-taking behaviors, problems associated with predicting adolescent behavior, peer relationships and decision making, sexual disinhibition, and the role of family relationships in adolescent decision making.

Key Words: children • adolescence • HIV vaccine trials • decisionmaking • HIV/AIDS

Journal of the International Association of Physicians in AIDS Care (JIAPAC), Vol. 4, No. 4, 89-92 (2005)
DOI: 10.1177/1545109705285033


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?